• Home
  •  
    Regions
    • Europe
    • UK & Ireland
    • DACH
    • Nordic
    • France
    • Southern Europe
    • Benelux
    • CEE
    • Asia
  •  
    Deals
    • Buyouts
    • Venture
    • Exits
    • Refinancings
    • Build-up
    • Turnaround
    • Secondaries
    • Advanced deals search
  •  
    Funds
    • Buyout
    • Venture
    • Mezzanine
    • Debt
    • Funds-of-funds
    • Secondaries
    • Fundraising pipelines
    • Advanced funds search
  •  
    GPs & LPs
    • GP profiles
    • LP profiles
    • GP news
    • LP news
    • Sponsors search
    • LPs search
  •  
    Secondaries
    • Deals
    • Funds
    • News
    • Analysis
  •  
    People
    • People moves
    • Analysis
    • In Profile
    • Q&A
    • Videos
    • Comment
  •  
    Analysis
    • In Profile
    • Fundraising
    • Q&A
    • Comment
    • Videos
    • Podcast
    • Reports
    • Data Snapshots
  •  
    Unquote Data
    • Deals search
    • Exits search
    • Funds search
    • Sponsors search
    • Advisers search
    • LPs search
    • League tables
    • Reports
  • Sign in
  • Sign in
    • You are currently accessing unquote.com via your Enterprise account.

      If you already have an account please use the link below to sign in.

      If you have any problems with your access or would like to request an individual access account please contact our customer service team.

      Phone: +44 (0)203 741 1137

      Email: Georgina.Lawson@acuris.com

      • Sign in
     
      • Newsletters
      • Account details
      • Contact support
      • Sign out
     
  • Follow us
    • Twitter
    • LinkedIn
  • Free Trial
  • Subscribe
Unquote
Unquote
  • Home
  • Regions
  • Deals
  • Funds
  • GPs & LPs
  • Secondaries
  • People
  • Analysis
  • Unquote Data
  • You are currently accessing unquote.com via your Enterprise account.

    If you already have an account please use the link below to sign in.

    If you have any problems with your access or would like to request an individual access account please contact our customer service team.

    Phone: +44 (0)203 741 1137

    Email: Georgina.Lawson@acuris.com

    • Sign in
 
    • Newsletters
    • Account details
    • Contact support
    • Sign out
 
Unquote
  • Buyouts

PAI Partners buys Armacell from Blackstone

  • Harriet Matthews
  • Harriet Matthews
  • 05 December 2019
  • Tweet  
  • Facebook  
  • LinkedIn  
  • Google plus  
  • Send to  

PAI Partners has acquired a majority stake in engineered foam producer Armacell alongside family office Kirkbi, which reinvested for a significant minority stake.

Armacell's management will continue to hold a minority stake in the business.

Unquote understands that the deal is based on an enterprise value of €1.4bn. The company's latest report shows a 2018 EBITDA of €106m.

Armacell

  • DEAL:

    SBO

  • VALUE:

    €1.4bn

  • LOCATION:

    Luxembourg

  • SECTOR:

    Building materials & fixtures

  • FOUNDED:

    1954

  • EBITDA:

    €106m

  • STAFF:

    3,054

  • VENDOR:

    Blackstone

Unquote sister publication Mergermarket reported that bidders in the process included Ardian, PAI Partners and CVC. US GP Clearlake was also a contender, via its portfolio company Unifrax.

PAI drew equity from PAI Europe VII, which held a final close on €5bn in March 2018 and was 40% deployed at the start of December 2019.

Blackstone said in a statement that it had invested in improving the company's energy efficiency during the investment period.

Previous funding
In 2000, CVC Capital Partners and Gilde Investment Management bought Armacell in a €304m MBO from Armstrong World Industries, where the company was formerly known as Armaflex.

In 2007, Investcorp bought Armacell in a €400m SBO from CVC  and Gilde.

Charterhouse acquired Armacell from Investcorp in a €500m SBO in April 2013.

Blackstone and Kirkbi acquired Armacell from Charterhouse in an SBO in 2016. The 2016 deal valued Armacell at €960m (10x its 2015 EBITDA). Deutsche Bank, BNP Paribas, ING and HSBC arranged a €560m senior debt package and €100m rolling credit facility to support the deal.

Company
Armacell produces engineered foams for thermal, acoustic and mechanical functions, including flexible foam for equipment insulation. It reported total sales of €610m in 2018 and has a headcount of 3,054.

The Luxembourg-headquartered company was founded in 1954 in Munster and operates 24 plants in 16 countries, with its main operations in Germany. Armacell was originally the insulation products branch of Armstrong World Industries, Armaflex, and was renamed Armacell in 2000.

People
Armacell
– Patrick Mathieu (CEO).
PAI Partners – Mathieu Paillat (partner); Philipp Meyer, (principal).

Advisers
Vendor
– Rothschild (M&A).

  • Tweet  
  • Facebook  
  • LinkedIn  
  • Google plus  
  • Send to  
  • Topics
  • Buyouts
  • Exits
  • DACH
  • Secondary buyout
  • Germany
  • PAI Partners
  • Blackstone Group

More on Buyouts

Clinical trials and biotechnology
Permira to take Ergomed private for GBP 703m

Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO

  • Buyouts
  • 04 September 2023
EMEA Public to Private M&A
Change of mind: Sponsors take to de-listing their own assets

EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater

  • Investments
  • 04 September 2023
HR software solutions providers
Main Capital’s Assessio to be sold to Pollen Street

Recruitment software company tripled in revenue under Main Capital’s ownership

  • Buyouts
  • 25 August 2023
Ice cream
Exponent divests ‘significant' stake in Meadow to Canadian investor

Since 2018, GP has diversified food ingredients company's focus beyond commodity dairy

  • Exits
  • 22 August 2023

Latest News

Fund closes in US dollars
  • Funds
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme

Multi-family office has seen strong appetite, with investor base growing since 2016 to more than 90 family offices, Meiping Yap told Unquote

  • 05 September 2023
Clinical trials and biotechnology
  • Buyouts
Permira to take Ergomed private for GBP 703m

Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO

  • 04 September 2023
Public sector software
  • Exits
Partners Group to release IMs for Civica sale in mid-September

Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017

  • 04 September 2023
EMEA Public to Private M&A
  • Investments
Change of mind: Sponsors take to de-listing their own assets

EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater

  • 04 September 2023
Back to Top
  • About Unquote
  • Advertise
  • Contacts
  • About Acuris
  • Terms of Use
  • Privacy Policy
  • Group Disclaimer
  • Twitter
  • LinkedIn

© Merger Market

© Mergermarket Limited, 10 Queen Street Place, London EC4R 1BE - Company registration number 03879547

Digital publisher of the year 2010 & 2013

Digital publisher of the year 2010 & 2013